TRDA · Entrada Therapeutics, Inc. · Analyst Estimates
Market Cap
$248.42M
Shares
38.94M
Analyst Estimates
Compare analyst forecasts for Entrada Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1689375
CUSIP
29384C108
13F (30d)
75 filings
75 filers
Visit website
Investor relations